Estradiol And Norethindrone Acetate Tablet
Product Images NDC 79929-012

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Estradiol And Norethindrone Acetate (NDC 79929-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Naari Pte. Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (210233 Outer)

Image Description (210233 Outer)
This is a medication information for Estradiol and Norethindrone Acetate Tablets, USP. Each film coated tablet contains 1mg of estradiol and 0.5mg of norethindrone acetate. This medication is available in 3 blister cards, each containing 28 tablets, and should be stored in a dry place protected from light at a temperature ranging from 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). The medication is prescription-only and comes with enclosed information for the patient, including a boxed warning.*
FDA Label Image

Image Description (Draft Labeling Text)

Image Description (Draft Labeling Text)
This is a medication bottle containing 28 tablets of Estradiol and Norethindrone Acetate Tablets, USP. The label with the product information and instructions is not available as only a peel and place label is present below the text.*
FDA Label Image

Image Description (Estradiol)

FDA Label Image

Image Description (Figure 1a)

FDA Label Image

Image Description (Figure 1b)

FDA Label Image

Image Description (Figure 2)

Image Description (Figure 2)
This is a table showing the frequency of hot flushes per week for a study comparing a placebo to 1 mg Estradiol and Norethindrone Acetate tablets. The level of hot flushes is rated as moderate to severe. No further information is available.*
FDA Label Image

Image Description (Figure 3)

FDA Label Image

Image Description (Figure 4)

Image Description (Figure 4)
This text appears to be a partial result of a study or research. The given text includes some codes and abbreviations that are not clear. Without further context or additional information, a useful description cannot be generated. Therefore, the text is not available for a meaningful interpretation.*
FDA Label Image

Image Description (Figure 5)

FDA Label Image

Image Description (Figure 6)

FDA Label Image

Image Description (Nor Acetate)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.